Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
ALX Oncology reports Q2 EPS (76c), consensus (77c)
Premium
The Fly
ALX Oncology reports Q2 EPS (76c), consensus (77c)
3M ago
ALX Oncology Enhances Board with Expert Appointment, Meets Nasdaq Standards
Premium
Company Announcements
ALX Oncology Enhances Board with Expert Appointment, Meets Nasdaq Standards
3M ago
ALX Oncology presents data from Phase 1 ASPEN-07 clinical trial
PremiumThe FlyALX Oncology presents data from Phase 1 ASPEN-07 clinical trial
5M ago
ALX Oncology price target raised to $25 from $20 at H.C. Wainwright
Premium
The Fly
ALX Oncology price target raised to $25 from $20 at H.C. Wainwright
6M ago
ALX Oncology reports Q1 EPS (71c), consensus (84c)
Premium
The Fly
ALX Oncology reports Q1 EPS (71c), consensus (84c)
6M ago
Cantor Fitzgerald biotech analyst holds an analyst/industry webinar
PremiumThe FlyCantor Fitzgerald biotech analyst holds an analyst/industry webinar
7M ago
ALX Oncology reports clinical data from Phase 1/2 trial of evorpacept
Premium
The Fly
ALX Oncology reports clinical data from Phase 1/2 trial of evorpacept
7M ago
ALX Oncology price target raised to $20 from $17.50 at H.C. Wainwright
Premium
The Fly
ALX Oncology price target raised to $20 from $17.50 at H.C. Wainwright
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100